UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The critical role of IL-34 in osteoclastogenesis

PloS one, 2011-04, Vol.6 (4), p.e18689-e18689

2011

Volltextzugriff (PDF)

Osteoclast lineage and function

Archives of biochemistry and biophysics, 2008-05, Vol.473 (2), p.132-138

2008

Volltextzugriff (PDF)

Mesenchymal stem cells

Annals of medicine (Helsinki), 2005-01, Vol.37 (7), p.469-479

Kalervo Väänänen, H.

2005

Volltextzugriff (PDF)

Estrogen and Testosterone Use Different Cellular Pathways to Inhibit Osteoclastogenesis and Bone Resorption

Journal of bone and mineral research, 2005-12, Vol.20 (12), p.2224-2232

2005

Volltextzugriff (PDF)

Serum Osteocalcin Is Not Associated with Glucose but Is Inversely Associated with Leptin across Generations of Nondiabetic Women

The journal of clinical endocrinology and metabolism, 2012-11, Vol.97 (11), p.4106-4114

2012

Volltextzugriff (PDF)

Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial

The American journal of clinical nutrition, 2005-11, Vol.82 (5), p.1115-1126

2005

Volltextzugriff (PDF)

Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women

Journal of bone and mineral research, 2007-01, Vol.22 (1), p.127-134

2007

Volltextzugriff (PDF)

Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1

Matrix biology, 2010-05, Vol.29 (4), p.287-294

2010

Volltextzugriff (PDF)

Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro

The Journal of biological chemistry, 2004-04, Vol.279 (18), p.18361-18369

2004

Volltextzugriff (PDF)

Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women

Journal of bone and mineral research, 2004-03, Vol.19 (3), p.386-393

2004

Volltextzugriff (PDF)

Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk

The journal of clinical endocrinology and metabolism, 2008-07, Vol.93 (7), p.2622-2632

2008

Volltextzugriff (PDF)

Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture

Journal of bone and mineral research, 2006-04, Vol.21 (4), p.616-625

2006

Volltextzugriff (PDF)

The effects of acute hyperinsulinemia on bone metabolism

Endocrine Connections, 2015-09, Vol.4 (3), p.155-162

2015

Volltextzugriff (PDF)

Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite

Molecular pharmacology, 2002-05, Vol.61 (5), p.1255-1262

2002

Volltextzugriff (PDF)

Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8

Endocrinology (Philadelphia), 2006-05, Vol.147 (5), p.2171-2182

2006

Volltextzugriff (PDF)

Membrane-bound carbonic anhydrases in osteoclasts

Bone (New York, N.Y.), 2007-04, Vol.40 (4), p.1021-1031

2007

Volltextzugriff (PDF)

Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

BMC cancer, 2009-10, Vol.9 (1), p.362-362, Article 362

2009

Volltextzugriff (PDF)

Urinary Osteocalcin as a Marker of Bone Metabolism

Clinical chemistry (Baltimore, Md.), 2005-03, Vol.51 (3), p.618-628

2005

Volltextzugriff (PDF)

Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption

Biochemical and biophysical research communications, 2005-10, Vol.335 (4), p.1095-1101

2005

Volltextzugriff (PDF)

Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells

Molecular and cellular endocrinology, 2008-07, Vol.289 (1), p.38-48

2008

Volltextzugriff (PDF)

A Rationale for Osteoclast Selectivity of Inhibiting the Lysosomal V-ATPase a3 Isoform

Calcified tissue international, 2010-09, Vol.87 (3), p.273-283

2010

Volltextzugriff (PDF)

Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts

Journal of bone and mineral research, 2004-09, Vol.19 (9), p.1432-1440

2004

Volltextzugriff (PDF)

Urinary osteocalcin and serum pro-C-type natriuretic peptide predict linear catch-up growth in infants

Journal of bone and mineral research, 2012-07, Vol.27 (7), p.1528-1535

2012

Volltextzugriff (PDF)

Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years

Journal of bone and mineral research, 2010-02, Vol.25 (2), p.393-403

2010

Volltextzugriff (PDF)

Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway

Cancer research (Chicago, Ill.), 2002-05, Vol.62 (9), p.2708-2714

2002

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(168)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(133)
Animals
(96)
Humans
(89)
Biological And Medical Sciences
(72)
Rats
(54)
Endocrinology & Metabolism
(51)
Female
(50)
Fundamental And Applied Biological Sciences. Psychology
(45)
Bone Resorption
(37)
Cells, Cultured
(35)
Osteoclast
(35)
Male
(34)
Medical Sciences
(34)
Cell Biology
(33)
Mice
(33)
Biochemistry & Molecular Biology
(29)
Tartrate-Resistant Acid Phosphatase
(29)
Osteoclasts - Cytology
(26)
Osteoclasts - Metabolism
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The critical role of IL-34 in osteoclastogenesis

Osteoclast lineage and function

Mesenchymal stem cells

Estrogen and Testosterone Use Different Cellular Pathways to Inhibit Osteoclastogenesis and Bone Resorption

Serum Osteocalcin Is Not Associated with Glucose but Is Inversely Associated with Leptin across Generations of Nondiabetic Women

Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial

Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women

Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1

Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro

Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women

Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk

Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture

The effects of acute hyperinsulinemia on bone metabolism

Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite

Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8

Membrane-bound carbonic anhydrases in osteoclasts

Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

Urinary Osteocalcin as a Marker of Bone Metabolism

Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption

Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells

A Rationale for Osteoclast Selectivity of Inhibiting the Lysosomal V-ATPase a3 Isoform

Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts

Urinary osteocalcin and serum pro-C-type natriuretic peptide predict linear catch-up growth in infants

Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years

Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway

Suchergebnisse filtern